Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | March 18, 2021 | March 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CASTLE BIOSCIENCES INC
Report date March 18, 2021 · Filed March 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,407 |
Reported balance
After 2021-03-18 transaction · row 1
1 source rowRow 1 · 2021-03-18 · Exercise / conversion · Acquired 12,229 · Balance 124,407 |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2029-07-23 | Direct | 18,666 |
Reported balance
After 2021-03-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-03-18 · Exercise / conversion · Disposed 12,229 · Balance 18,666 F4: 25% of the 30,895 shares originally subject to the option vested on August 1, 2020, and the remaining shares vest in 36 equal monthly installments thereafter. |
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 628,410 |
Reported balance
Holding disclosure · report date 2021-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 628,410 F1: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"), MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F2: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. |
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 717 |
Reported balance
Holding disclosure · report date 2021-03-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 717 F3: Held by MOD Partners, LLC ("MOD LLC"). The Reporting Person is the President and a member of MOD LLC and has voting and investment power over the shares held by MOD LLC. The Reporting Person disclaims beneficial ownership of the shares held by MOD LLC as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"), MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP.
F2: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F3: Held by MOD Partners, LLC ("MOD LLC"). The Reporting Person is the President and a member of MOD LLC and has voting and investment power over the shares held by MOD LLC. The Reporting Person disclaims beneficial ownership of the shares held by MOD LLC as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F4: 25% of the 30,895 shares originally subject to the option vested on August 1, 2020, and the remaining shares vest in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 25,967 | $48.37 | $1,255,971.86 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 11 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 938,088 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F15 · price: This transaction was executed in multiple trades at prices ranging from $47.800 to $48.790, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 5,624 | $47.13 | $265,047.87 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 10 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 964,055 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F14 · price: This transaction was executed in multiple trades at prices ranging from $46.800 to $47.770, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,990 | $46.32 | $184,804.83 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 9 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 969,679 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: These transactions were executed in multiple trades at prices ranging from $45.800 to $46.790, inclusive. The prices reported above reflect the weighted-average sale prices. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,500 | $48.24 | $168,829.50 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 8 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 973,669 F10 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F13 · price: This transaction was executed in multiple trades at prices ranging from $48.000 to $48.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,475 | $47.36 | $164,562.10 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 7 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 977,169 F10 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F12 · price: This transaction was executed in multiple trades at prices ranging from $47.000 to $47.980, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 4,260 | $46.59 | $198,460.62 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 6 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 980,644 F10 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F11 · price: This transaction was executed in multiple trades at prices ranging from $46.000 to $46.990, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,295 | $48.26 | $159,003.52 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 5 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 984,904 F6 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F9 · price: This transaction was executed in multiple trades at prices ranging from $48.000 to $48.820, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,894 | $47.39 | $184,524.98 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 988,199 F6 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $47.000 to $47.990, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 4,080 | $46.58 | $190,042.32 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 992,093 F6 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $46.000 to $46.995, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 19,576 | $47.07 | $921,383.59 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 996,173 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $46.800 to $47.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 20:08 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 19,758 | $46.33 | $915,309.11 |
DisclosureSEC source: 0001447362-20-000211 · wf-form4_159968211664689.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,015,749 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: These transactions were executed in multiple trades at prices ranging from $45.800 to $46.790, inclusive. The prices reported above reflect the weighted-average sale prices. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,602 | $46.09 | $119,926.18 |
DisclosureSEC source: 0001447362-20-000203 · wf-form4_159924991963365.xml · nonDerivative · entry 6 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,035,507 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F11 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,600 | $46.10 | $119,860.00 |
DisclosureSEC source: 0001447362-20-000203 · wf-form4_159924991963365.xml · nonDerivative · entry 5 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,038,109 F5 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F10 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.29, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 24,998 | $46.00 | $1,149,908.00 |
DisclosureSEC source: 0001447362-20-000203 · wf-form4_159924991963365.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,040,709 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F9 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 300 | $46.02 | $13,806.00 |
DisclosureSEC source: 0001447362-20-000203 · wf-form4_159924991963365.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,065,707 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $46.01 to $46.04, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 400 | $46.02 | $18,408.00 |
DisclosureSEC source: 0001447362-20-000203 · wf-form4_159924991963365.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,066,007 F5 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.04, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 6,665 | $45.99 | $306,523.35 |
DisclosureSEC source: 0001447362-20-000203 · wf-form4_159924991963365.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,066,407 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.16, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 21:45 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,147 | $46.03 | $98,826.41 |
DisclosureSEC source: 0001447362-20-000199 · wf-form4_159908308910869.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,073,072 F8 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F9 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 21:45 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,200 | $46.02 | $101,244.00 |
DisclosureSEC source: 0001447362-20-000199 · wf-form4_159908308910869.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,075,219 F6 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 21:45 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 35,963 | $45.95 | $1,652,499.85 |
DisclosureSEC source: 0001447362-20-000199 · wf-form4_159908308910869.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,077,419 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.29, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:45 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,228 | $45.84 | $377,171.52 |
DisclosureSEC source: 0001447362-20-000199 · wf-form4_159908308910869.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,113,382 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $45.96, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,609 | $46.15 | $166,555.35 |
DisclosureSEC source: 0001447362-20-000195 · wf-form4_159890429738649.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,121,610 F8 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F9 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.46, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,605 | $46.16 | $166,406.80 |
DisclosureSEC source: 0001447362-20-000195 · wf-form4_159890429738649.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,125,219 F6 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.47, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 48,487 | $46.06 | $2,233,311.22 |
DisclosureSEC source: 0001447362-20-000195 · wf-form4_159890429738649.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,128,824 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.47, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 16,239 | $45.89 | $745,207.71 |
DisclosureSEC source: 0001447362-20-000195 · wf-form4_159890429738649.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,177,311 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.01, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 100 | $46.00 | $4,600.00 |
DisclosureSEC source: 0001447362-20-000193 · wf-form4_159855867654281.xml · nonDerivative · entry 6 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,193,550 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 70 | $46.00 | $3,220.00 |
DisclosureSEC source: 0001447362-20-000193 · wf-form4_159855867654281.xml · nonDerivative · entry 5 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,193,650 F5 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 26, 2020 Filed Aug 27, 2020 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 4,879 | $45.85 | $223,692.39 |
DisclosureSEC source: 0001447362-20-000193 · wf-form4_159855867654281.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,193,720 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $45.800 to $46.100, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 200 | $46.05 | $9,209.00 |
DisclosureSEC source: 0001447362-20-000193 · wf-form4_159855867654281.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,198,599 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $46.000 to $46.090, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 200 | $46.05 | $9,209.00 |
DisclosureSEC source: 0001447362-20-000193 · wf-form4_159855867654281.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,198,799 F5 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $46.000 to $46.090, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 20:04 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 17,148 | $45.90 | $787,007.46 |
DisclosureSEC source: 0001447362-20-000193 · wf-form4_159855867654281.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,198,999 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.800 to $46.125, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 20:11 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,877 | $45.90 | $407,454.30 |
DisclosureSEC source: 0001447362-20-000191 · wf-form4_159838628445835.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,216,147 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.01, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:11 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 6,017 | $45.85 | $275,879.45 |
DisclosureSEC source: 0001447362-20-000191 · wf-form4_159838628445835.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,225,024 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $45.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 300 | $46.06 | $13,818.00 |
DisclosureSEC source: 0001447362-20-000188 · wf-form4_159804038445523.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,231,041 F7 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $46.03 to $46.08, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 100 | $46.03 | $4,603.00 |
DisclosureSEC source: 0001447362-20-000188 · wf-form4_159804038445523.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,231,341 F6 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,395 | $45.84 | $384,826.80 |
DisclosureSEC source: 0001447362-20-000188 · wf-form4_159804038445523.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,231,441 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $46.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 20:06 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,574 | $45.83 | $392,946.42 |
DisclosureSEC source: 0001447362-20-000188 · wf-form4_159804038445523.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,239,836 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.80 to $45.90, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,107 | $43.08 | $133,849.56 |
DisclosureSEC source: 0001447362-20-000146 · wf-form4_159467072068838.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,248,410 F8 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.47, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 5,256 | $43.07 | $226,375.92 |
DisclosureSEC source: 0001447362-20-000146 · wf-form4_159467072068838.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,251,517 F6 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.47, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 23,902 | $44.00 | $1,051,688.00 |
DisclosureSEC source: 0001447362-20-000146 · wf-form4_159467072068838.xml · nonDerivative · entry 2 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,256,773 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $43.80 to $44.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:05 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 30,725 | $43.30 | $1,330,392.50 |
DisclosureSEC source: 0001447362-20-000146 · wf-form4_159467072068838.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,280,675 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020, as amended on June 1, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $42.80 to $43.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:13 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 100 | $43.11 | $4,311.00 |
DisclosureSEC source: 0001447362-20-000139 · wf-form4_159320236453271.xml · nonDerivative · entry 1 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,311,400 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020. F2 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F3 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 4,048 | $43.07 | $174,347.36 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 10 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,311,500 F10 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F14 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.62, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 3,959 | $43.07 | $170,514.13 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 9 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,315,548 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F13 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.33, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 17,329 | $43.08 | $746,533.32 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 8 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,319,507 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020. F12 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.38, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 300 | $44.05 | $13,215.00 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 7 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,336,836 F10 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,766 | $43.53 | $120,403.98 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 6 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,337,136 F10 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 LP on March 13, 2020. F11 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.98, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 300 | $44.15 | $13,245.00 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 5 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,339,902 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F9 · price: This transaction was executed in multiple trades at prices ranging from $44.05 to $44.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 2,700 | $43.52 | $117,504.00 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 4 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,340,202 F7 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC 2018 QP LP on March 13, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.93, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 00:18 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | SaleCommon Stock | 8,016 | $43.91 | $351,982.56 |
DisclosureSEC source: 0001447362-20-000136 · wf-form4_159295791963527.xml · nonDerivative · entry 3 Cook Joseph C. III · CIK 0001783205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,342,902 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by MGC Venture Partners 2013, L.P. ("MGC 2013 LP") on March 13, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $43.75 to $44.41, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by MGC 2013 LP, MGC Venture Partners 2018, L.P. ("MGC 2018 LP"), MGC Venture Partners QP 2018, L.P. ("MGC 2018 QP LP") and MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP"). MGC 2013 GP is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP LP. F4 · ownership.nature: The Reporting Person is a managing director of MGC 2013 GP and a managing partner of MGC 2018 GP, and shares voting and investment power over the shares held by MGC 2013 LP, MGC 2018 LP, MGC 2018 QP LP and MGC 2013 GP. The Reporting Person disclaims beneficial ownership of the shares held by MGC 2013 GP, MGC 2018 GP, MGC 2013 LP, MGC 2018 LP and MGC 2018 QP LP as reported herein, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.